
tony w
Title: Promise From a New Weight-Loss Drug
Category: Health News
Created: 7/1/2015 12:00:00 AM
Last Editorial Review: 7/2/2015 12:00:00 AM
The vast majority of consumers recognize that multivitamins, calcium and/or vitamin D supplements can help fill nutrient gaps but should not be viewed as replacements for a healthy diet, according to…
Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, helped obese people lose an average of 18 pounds (eight kilograms), a yearlong study said Wednesday. Most patients were able to keep the weight off for the duration of the 56-week study on the drug marketed as Saxenda by Novo Nordisk, according to the findings published in the New England Journal of Medicine.
European Spine Journal
European Spine Journal
Tropical Doctor
UAB Medicine
Movement Disorders
Trials
European Journal of Pain